An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function

NCT03674476 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

NAFLD
Nonalcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis

Interventions

DRUG: BMS-986036

Sponsor

Bristol-Myers Squibb